Madrigal Pharmaceuticals Inc
F:YDO1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Madrigal Pharmaceuticals Inc
F:YDO1
|
US |
|
Nice Ltd
F:NSY
|
IL |
|
N4 Pharma PLC
LSE:THAT
|
UK |
|
C
|
Credit Agricole SA
XHAM:XCA
|
FR |
|
C
|
Charles Schwab Corp
XMUN:SWG
|
US |
|
C
|
Cheesecake Factory Inc
SWB:CF2
|
US |
|
A
|
Advanced Micro Devices Inc
XMUN:AMD
|
US |
|
M
|
Microsoft Corp
DUS:MSF
|
US |
|
Bentley Systems Inc
F:BS81
|
US |
|
Lynch Group Holdings Ltd
ASX:LGL
|
AU |
|
A
|
Ageas SA
MIL:AGS
|
BE |
|
A
|
Akwel SA
F:MW4
|
FR |
|
S
|
SunCoke Energy Inc
XBER:S01
|
US |
|
LendingClub Corp
NASDAQ:HAPN
|
US |
|
Newcap Holding A/S
F:25N0
|
DK |
|
Hycroft Mining Holding Corporation
NASDAQ:HYMC
|
US |
|
Goldiam International Ltd
NSE:GOLDIAM
|
IN |
|
A
|
Almaden Minerals Ltd
XTSX:AMM
|
CA |
|
D
|
Daimler Truck Holding AG
XBER:DTG
|
DE |
|
SunCoke Energy Inc
F:S01
|
US |
|
Japan Excellent Inc
F:81L
|
JP |
|
E
|
Engine Gaming and Media Inc
NASDAQ:GAME
|
CA |
|
Moelis & Co
NYSE:MC
|
US |
|
Invinity Energy Systems PLC
OTC:IESVF
|
JE |
Wall St Price Targets
YDO1 Price Targets Summary
Madrigal Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for YDO1 is 475.87 EUR with a low forecast of 376.24 EUR and a high forecast of 695.69 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is YDO1's stock price target?
Price Target
475.87
EUR
According to Wall Street analysts, the average 1-year price target for YDO1 is 475.87 EUR with a low forecast of 376.24 EUR and a high forecast of 695.69 EUR.
What is the Revenue forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Revenue has been 102%. The projected CAGR for the next 8 years is 27%.
What is the Gross Profit forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
26%
The compound annual growth rate for Gross Profit over the next 8 years is 26%.
